PA
NVO

Perceptive Advisors’s Novo Nordisk NVO Stock Holding History

Perceptive Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-233,320
Closed -$6.32M – 195
2016
Q1 		$6.32M Buy
233,320
+214,240
+1,123% +$5.74M 0.55% 48
2015
Q4 		$554K Buy
19,080
+8,400
+79% +$232K 0.04% 100
2015
Q3 		$290K Buy
10,680
+6,000
+128% +$170K 0.02% 118
2015
Q2 		$128K Buy
+4,680
New +$132K 0.01% 168

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Perceptive Advisors's NVO Position: Q2 2016 in Review

Perceptive Advisors sold out of Novo Nordisk (NVO) in Q2 2016, closing a stake of 233,320 shares — an estimated $6.32M sold.

Perceptive Advisors first reported a position in NVO in Q2 2015 and held it in 4 quarters. The position peaked at $6.32M in Q1 2016. 530 funds tracked by Wall St. Rank hold NVO as of Q2 2016.

  • Perceptive Advisors reported no remaining Novo Nordisk position as of Q2 2016 after selling out during the quarter.
  • Perceptive Advisors sold 233,320 Novo Nordisk shares in Q2 2016, an estimated $6.32M.
  • Perceptive Advisors first reported a position in Novo Nordisk in Q2 2015 and held it in 4 quarters.
  • Perceptive Advisors's Novo Nordisk position peaked at $6.32M in Q1 2016.
  • 530 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2016.

Based on Perceptive Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.